EVLT

LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein.

Retrieved on: 
Tuesday, September 21, 2021
Mark (given name), Marketing, LSO, Patient, SAS, Branch retinal vein occlusion, EVLT, 3D printing, Pharmaceutical industry

LILLE, France, Sept. 21, 2021 /PRNewswire/ -- LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack assisted system, the LUMESEAL laser platform.

Key Points: 
  • LILLE, France, Sept. 21, 2021 /PRNewswire/ -- LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack assisted system, the LUMESEAL laser platform.
  • The third-generation laser system incorporates the same 1470nm laser design combined with the RINGLIGHT fibers range design which has shown superior performance and clinical evidence compared to other alternative configurations.
  • With more than 20 years' experience, the French company LSO Medical is a key player in the design, production and marketing of innovative medical laser systems.
  • Constantly aiming at exploiting and bringing technological innovations to doctors and their patients, LSO Medical is today one of the world leaders in the endothermic laser technique.

LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein.

Retrieved on: 
Tuesday, September 21, 2021
Mark (given name), Marketing, LSO, Patient, SAS, Branch retinal vein occlusion, EVLT, 3D printing, Pharmaceutical industry

LILLE, France, Sept. 21, 2021 /PRNewswire/ -- LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack assisted system, the LUMESEAL laser platform.

Key Points: 
  • LILLE, France, Sept. 21, 2021 /PRNewswire/ -- LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack assisted system, the LUMESEAL laser platform.
  • The third-generation laser system incorporates the same 1470nm laser design combined with the RINGLIGHT fibers range design which has shown superior performance and clinical evidence compared to other alternative configurations.
  • With more than 20 years' experience, the French company LSO Medical is a key player in the design, production and marketing of innovative medical laser systems.
  • Constantly aiming at exploiting and bringing technological innovations to doctors and their patients, LSO Medical is today one of the world leaders in the endothermic laser technique.